SciELO - Scientific Electronic Library Online

 
vol.35 número5Parvovirus B19: Un virus ADN asociado a múltiples manifestaciones cutáneas índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista chilena de infectología

versión impresa ISSN 0716-1018

Resumen

RABAGLIATI, Ricardo. Update in the diagnostic and therapeutic approach of invasive aspergillosis in adult population. Rev. chil. infectol. [online]. 2018, vol.35, n.5, pp.531-544. ISSN 0716-1018.  http://dx.doi.org/10.4067/s0716-10182018000500531.

The invasive fungal disease produced by Aspergillus spp., is the infection by filamentous fungi most frequently reported among immunocompromised individuals and responsible for a very high mortality in this group of patients. In recent years, important advances have been made both from the diagnostic and therapeutic point of view. At present, a series of risk factors associated with its development have been identified, allowing the categorization of patients in high, intermediate and low risk of invasive aspergillosis (IA); and diagnostic criteria have also been established that consider factors of the host, traditional mycological laboratory, biomarkers such as galactomannan and 1→3-β-d-glucan, together with the better understanding and interpretation of the tomographic images that have allowed to reach a consensus on the diagnostic categories. This added to the incorporation of new antifungals and therapeutic strategies in different scenarios, have allowed decreasing the associated mortality. In this review, are updated the epidemiological aspects, the risk factors, the diagnosis, prevention and prophylaxis as well as the therapeutic confrontation, including strategies for the use of empirical, precocious and directed antifungal therapy, as well as the most relevant aspects of the first-choice and alternative antifungals for the IA management.

Palabras clave : Invasive aspergillosis; galactomannan; antifungal therapy; immunocompromised patients.

        · resumen en Español     · texto en Español     · Español ( pdf )